Effect of L-Ascorbic Acid on the Climbing Ability and Protein Levels in the Brain of Drosophila Model of Parkinson's Disease

REFERENCES

• Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Dopaminergic loss and inclusion body formation in alpha synuclein in mice: implication for neurogenerative disorders. Science. 2000;287:1265–9.
   PubMed Web of Science ®Google Scholar
• Vander Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Haufmann S, Hofele K, Spooren WP, Ruegg M.A, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G. Neuropathology in mice expressing human alpha synuclein. J Neurosci. 2000;15:6021–9.
   Google Scholar
• Dauer W, Przedborsk S. Parkinson disease: mechanisms and models. Neuron. 2003;39:889–909.
   PubMed Web of Science ®Google Scholar
• Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature. 2000;404:394–8.
   PubMed Web of Science ®Google Scholar
• Pendleton RG, Parvez F, Sayed M, Hillman R. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther. 2002;300:91–6.
   PubMed Web of Science ®Google Scholar
• Munoz-Soriano V, Paricio N. Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies. Parkinson's Dis. 2011;2011:1–14.
   Web of Science ®Google Scholar
• Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368–76.
   PubMed Web of Science ®Google Scholar
• Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373:2055–66.
   PubMed Web of Science ®Google Scholar
• Naoi M, Maruyama W. Future of Neuroprotection in Parkinson's disease. Parkinson Relat Disord. 2001;8:139–45.
   PubMed Web of Science ®Google Scholar
• Lü JM, Nurko J, Weakley SM, Jiang J, Kouglas P, Lin PH, Yao Q, Chen C. Molecular mechanisms and clinical application of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010;16:RA93–100.
   PubMed Web of Science ®Google Scholar
• Ono K, Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha synuclein fibrils in vitro. J Neurochem. 2006;97:105–15.
   PubMed Web of Science ®Google Scholar
• Pal R, Miranda M, Narayan M. Nitrosative stress induced Parkinsonian Lewy like aggregates prevented through polyphenolic phytochemical analog intervention. Biochem Biophys Res Commun. 2011;404:324–29.
   Web of Science ®Google Scholar
• Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis. 2000;7:240–50.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Kanski J. Brain protein oxidation in age related neurodegenerative disorders that are associated with aggregated proteins. Mech Age Dev. 2001;15:1945–62.
   Google Scholar
• Giasson BI, Ischiropoulos H, Lee VM, Trojanowski JQ. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's disease. Free Radic Biol Med. 2002;32:1264–75.
   PubMed Web of Science ®Google Scholar
• Cookson MR. The biochemistry of Parkinson's disease. Ann Rev Biochem. 2005;74:29–52.
   PubMed Web of Science ®Google Scholar
• Abbott RA, Cox M, Markus H, Temkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr. 1992;46:879–84.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Ara G, Beg T, Afzal M, Faisal M. Protective role of Plumbago zeylanica extract against toxic effects of ethinylestradiol in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ)Bg9 and cultured human peripheral blood lymphocytes. Altern Med Stud. 2011;107: 26–9.
   Google Scholar
• Bradford MM. Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Ann Biochem. 1976;72:248–54.
   Google Scholar
• Noor R, Mittal S, Iqbal J. Superoxide dismutase: applications and relevance to human diseases. Med Sci Monit. 2002;8:RA210–5.
   PubMedGoogle Scholar
• Fahn S. The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high dosage antioxidants in an attempt to slow the progression of the illness. Ann New York Acad Sci. 1989;570:186–96.
   PubMed Web of Science ®Google Scholar
• Sinonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Ann Rev Pharmacol Toxicol. 1996;36:83–106.
   PubMed Web of Science ®Google Scholar
• Pardo B, Mena MA, Fahn S, Yebenes JG. Ascorbic acid protects against levodopa induced neurotoxicity on a catecholamine rich human neuroblastoma cell line. Mov Disord. 1993;8:278–84.
   PubMed Web of Science ®Google Scholar
• Etminan M, Gill S, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta analysis. Lancet Neurol. 2005;4:362–65.
   Web of Science ®Google Scholar
• Fernandez-Calle P, Jinénez-Jiménez FJ, Molina JA, Cabrera-Valdivia F, Vazguez A, Urra DG, Bermejo F, Matallana MC, Codoceo R. Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease. J Neurol Sci. 1993;18:25–8.
   Google Scholar
• Mytilineous C, Walker RH, Jnobaptiste R, Obanow CW. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress. J Pharmacol Exp Ther. 2003;304:797–800.
   Web of Science ®Google Scholar
• Kostrzewa RM, Kostrzewa JP, Brus R. Neuroprotective and neurotoxic roles of levodopa (l-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids. 2002;23:57–63.
   PubMed Web of Science ®Google Scholar
• Mazzio EA, Close F, Solimanan KFA. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. Int J Mol Sci. 2011;12:506–69.
   PubMed Web of Science ®Google Scholar
• Amer DA, Irvine GB, El-Agnaf OM. Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders. Exp Brain Res. 2006;173:223–33.
   PubMed Web of Science ®Google Scholar
• Caruana M, Hogen T, Levin J, Hillmer A, Giese A, Vassallo N. Inhibition and disaggregation of α-synuclein oligomer by natural polyphenolic compounds. FEBS Lett. 2011;585:1113–20.
   PubMed Web of Science ®Google Scholar
• Siddique YH, Ara G, Jyoti S, Afzal M. Effect of capsacin on the climbing ability in Drosophila model of Parkinson's disease. Am J Drug Discov Dev. 2012;2:50–4.
   Google Scholar
• Siddique YH, Ara G, Jyoti S, Afzal M. Protective effect of curcumin in transgenic Drosophila melanogaster model of Parkinson's disease in Drosophila melanogaster. Altern Med Stud. 2012;2e:7–9.
   Google Scholar
• Siddique YH, Ara G, Jyoti S, Afzal M. The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease. J Diet Suppl. 2012;9:1–8.
   PubMedGoogle Scholar
• Siddique YH, Jyoti S, Naz F, Afzal M. Protective effect of apigenin in transgenic Drosophila melanogaster model of Parkinson's disease. Pharmacologyonline. 2011;3:790–5.
   Google Scholar
• Padayatty SJ, Katz A, Wang Y, Eck P, Know O, Lee JH, Chen S, Corpe C, Dutta SK, Levine M. Vitamin C as an antioxidant; evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22:18–35.
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione–ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269:9397–400.
   PubMed Web of Science ®Google Scholar
• Wilson JX. Regulation of vitamin C transport. Ann Rev Mutat. 2005;25:105–25.
   Google Scholar
• Auluck PK, Chan HYE, Trojanowski JQ, Lee VMY, Bonini NM. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 2002;295:865–8.
   PubMed Web of Science ®Google Scholar
• Jia H, Li X, Gao H, Feng Z, Li X, Zhao L, Jia X, Zhang H, Liu J. High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease. J Neurosci Res. 2008;86:2083–90.
   PubMed Web of Science ®Google Scholar
• Long J, Gao H, Sun L, Liu J, Zhao-Wilson X. Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends life-span in Drosophila Parkinson's disease model. Rejuvenation Res. 2009;12:321–31.
   PubMed Web of Science ®Google Scholar
• Festing MFW, Baumans V, Combes DR, Halder M, Hendricsen FM, Howard BR, Lowell DP, Moore GJ, Overend P, Wilson MS. Reducing the use of laboratory animals in biomedical research: problems and possible solutions. Altern Lab Anim. 1998;26:283–301.
   PubMed Web of Science ®Google Scholar
• Benford DJ, Hanley AB, Bottrill K, Oehlschlager S, Balls M, Branca F, Castengnaro JJ, Descotes J, Hemminiki K, Lindsay D, Schitter B. Biomarkers as predictive tools in toxicity testing. The report and recommendations of EVCAM workshop. Altern Lab Anim. 2000;28:119–31.
   Web of Science ®Google Scholar
• Avanesian A, Semmani S, Jafri M. Can Drosophila melanogaster represent a model system the detection of reproductive adverse drug reactions? Drug Discov Today. 2009;14:761–6.
   PubMed Web of Science ®Google Scholar